corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 18617

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Taylor L
More drug price cuts in Greece
Pharma Times 2010 Aug 20
http://www.pharmatimes.com/Article/10-08-20/More_drug_price_cuts_in_Greece.aspx


Full text:

Greece has announced that the price of certain drugs are to be reduced 10.41% and that it is drawing up a second list of medicines which will no longer be eligible for reimbursement.

The 10.41% retail price cuts announced by the economics ministry will be for a range of drugs used in the treatment of serious diseases, licensed for hospital use or prescribing by specialists only, and provisions will be put in place to enable patients to obtain them from pharmacies. The drugs involved have not been identified, but analysts at IHS Global Insight suggest that they will include biotechnology drugs used in the treatment of cancer, and possibly some orphan products. What is certain, they add, is that products whose prices are now to be cut will not be those which were included in the average 27% across-the-board price cut introduced by the government on a temporary basis in May.

Meantime, the national organisation for medicines (EOF) is preparing a second “negative” list of drugs that will no longer be entitled to reimbursement. 842 products will be on the list, including many for which over-the-counter (OTC) versions are already available, such as vitamin supplements, laxatives, antacids and obesity treatments, but the newspaper Naftemporiki reports that it will also include drugs which are generally prescription-only, such as some non-steroidal anti-inflammatory drugs (NSAIDs), and treatments for erectile dysfunction, attention deficit hyperactivity disorder (ADHD) and smoking cessation.

Naftemporiki also reports that the introduction of the first negative list, in May, has resulted in a significant decline in sales of many of the 253 drugs for which reimbursement was withdrawn. This could indicate that some patients are no longer accessing essential drugs, which may lead to manufacturers cutting their prices to ensure that they can still afford the treatments they need after they are no longer reimbursed, it says.

In other news, it is reported that the repricing of around 12,000 drugs, based on the average of the three lowest-priced countries in the European Union (EU), has being delayed, but the new prices are expected to be implemented on September 1. They will replace May’s average 27% temporary cuts.

Links
www.ihsglobalinsight.com
www.naftemporiki.gr

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909